Cardiology

Trials, guidelines and practice across cardiovascular medicine.

Incretin Drugs in Heart Failure: BMJ Protocol for Cardiovascular Review

BMJ protocol outlines a systematic review of GLP-1 and dual GIP/GLP-1 drugs in patients with and without heart failure, focusing on cardiovascular outcomes.

By Dr. Aishwarya N., MBBS · 4 days ago · 5 min read

Cardiology·FDA

FDA class 2 recalls hit Medtronic cardiac device tools

FDA posted three Class 2 recalls for Medtronic cardiac programming and interrogation tools used in implant and follow-up…

4 days ago

Cardiology·medRxiv

Single-cell plaque profiling maps symptomatic atherosclerosis signatures

Single-cell and single-nucleus profiling of carotid plaques linked symptomatic atherosclerosis to vascular wall cell states and genetic risk…

4 days ago

Cardiology·AHA

Cardiac Arrest CPR Program Failed to Improve Survival in North Carolina

A five-year North Carolina trial found a community CPR and EMS intervention did not improve survival after out-of-hospital…

4 days ago

Cardiology·AHA

Sacubitril/Valsartan Linked to Less AFib Recurrence After Ablation

In older adults with hypertension, sacubitril/valsartan was tied to fewer AFib recurrences after ablation than valsartan alone in…

4 days ago

Cardiology·AHA

Left bundle branch pacing cut cardiac events in heart block trial

A nearly 700-patient trial found left bundle branch pacing reduced death, heart failure hospitalization, and pacing-induced cardiomyopathy.

4 days ago

Cardiology·AHA

AHA launches Center for the Brain to advance heart-brain research

The American Heart Association is creating a Center for the Brain to expand research on heart-brain connections, stroke…

4 days ago

Cardiology·PubMed

Maternal Cardiovascular Health in Pregnancy Linked to Offspring Health at 10 to 14 Years

Better cardiovascular health during pregnancy was associated with better offspring cardiovascular health in early adolescence in a multinational…

4 days ago

Cardiology·ACC-PRO

Rezera IPO to Fund NLRP3 Inhibitor Phase 3 in Peripheral Artery Disease

Rezera seeks up to $181 million to advance ruvonoflast into phase 3 testing in peripheral artery disease after…

4 days ago

Cardiology·Nature

Type A Aortic Dissection Malperfusion Raises Early Surgical Mortality

In 1,021 surgically treated type A aortic dissection cases, malperfusion raised early mortality, especially with cerebral involvement.

4 days ago

Cardiology

Trials, guidelines and practice across cardiovascular medicine.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.